Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Clinical trial NCT03420963 · TERMINATED

Trial details

NCT number: NCT03420963
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Cutaneous Melanoma Recurrent Lip and Oral Cavity Carcinoma Recurrent Malignant Endocrine Neoplasm Recurrent Malignant Female Reproductive System Neoplasm Recurrent Malignant Male Reproductive System Neoplasm Recurrent Malignant Mesothelioma Recurrent Malignant Neoplasm of Multiple Primary Sites Recurrent Malignant Oral Neoplasm Recurrent Malignant Pharyngeal Neoplasm Recurrent Malignant Skin Neoplasm Recurrent Malignant Soft Tissue Neoplasm Recurrent Malignant Solid Neoplasm

Start date: 2018-08-31
Primary completion: 2026-02-26
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.